Skip to main content

Syndicate contentradiation

SNM and coalition of professional organizations call for action

RESTON, Va. -- SNM and a coalition of eight other organizations have issued a white paper urging Congress to take steps to maintain adequate supplies of Molybdenum-99 (Mo-99), a radioactive substance that is the basis for a common medical isotope used in more than 80 percent of all nuclear medicine procedures.

The 15-Minute Genome 2009 Industrial Physics Forum features faster, cheaper genome sequencing

College Park, MD (July 27, 2009) -- In the race for faster, cheaper ways to read human genomes, Pacific Biosciences is hoping to set a new benchmark with technology that watches DNA being copied in real time.

Surgery remans an option for advanced lung cancer

MAYWOOD, Il. -- In recent years, oncologists have debated whether patients with a certain type of advanced lung cancer would benefit from surgery.

Human cells secrete cancer-killing protein, UK study finds

Human cells are able to secrete a cancer-killing protein, scientists at the University of Kentucky's Markey Cancer Center have found.

Studies shed light on preserving fertility among cancer patients

PITTSBURGH, July 20 -- Cancer treatment has come a long way, leading to a multitude of therapy options and improved survival rates. These successes, however, have created a challenge for young cancer patients since chemotherapy and radiation treatments that often save lives threaten fertility.

RI Hospital first in country to enroll patient in new study for recurrent chest wall breast cancer

PROVIDENCE -- Rhode Island Hospital is one of only four sites across the country to participate in a new clinical trial called the DIGNITY Study. The study will investigate the effectiveness of a chemotherapeutic agent, ThermoDox, used in conjunction with mild hyperthermia (a form of heat therapy) for treating recurrent chest wall breast cancer.

Falling birth rates shift rotavirus epidemics

Fewer births in states such as California may be delaying the annual onset of a common intestinal virus in the southwest, according to epidemiologists. The timing of infectious outbreaks in other locations such as the northeast remains more or less unchanged.

Rotavirus is a leading cause of diarrhea among children, both in the developed and developing world.

Research identifies successful new treatment for Hodgkin's lymphoma, reduces long-term risks

PROVIDENCE, RI -- New research led by Cindy Schwartz, MD, of Hasbro Children's Hospital has identified a new chemotherapy regimen for pediatric Hodgkin lymphoma (HL) patients. The new treatment enhances efficacy through dose-dense drug delivery while simultaneously reducing the long-term risks presented by high cumulative dose chemotherapy.

New oral agents may prevent injury after radiation exposure

(Boston) -- Researchers from Boston University School of Medicine (BUSM) and collaborators have discovered and analyzed several new compounds, collectively called the ''EUK-400 series,'' which could someday be used to prevent radiation-induced injuries to kidneys, lungs, skin, intestinal tract and brains of radiological terrorism victims.

Australian researchers identify genes that cause melanoma

Scientists from the Queensland Institute of Medical Research (QIMR) have found two new genes that together double a person's risk of developing melanoma.

Prostate cancer patients disease free after five years likely to be disease free after 10 years

Prostate cancer patients who receive brachytherapy and remain free of disease for five years or greater are unlikely to have a recurrence at 10 years, according to a study in the July 1 issue of the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO).

Brachytherapy is the placement of radioactive sou

Study shows PET can measure effectiveness of novel breast cancer treatment

RESTON, Va. -- A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography (PET) scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended.

Blood stem cell growth factor reverses memory decline in mice

Tampa, FL (July 1, 2009) -- A human growth factor that stimulates blood stem cells to proliferate in the bone marrow reverses memory impairment in mice genetically altered to develop Alzheimer's disease, researchers at the University of South Florida and James A. Haley Hospital found.

MIT: A new approach to engineering for extreme environments

CAMBRIDGE, Mass.--Composite materials such as fiberglass, which take on a mix of properties of their constituent compounds, have been around for decades. Now, an MIT materials scientist is taking composites to the nanoscale, where entirely new properties, not found in any of the original compounds, can emerge.

Study challenges routine use of MRI scans to evaluate breast cancer

PHILADELPHIA (June 25, 2009) -- Reviewing the records of 577 breast cancer patients, Fox Chase Cancer Center researchers found that women with newly diagnosed breast cancer who receive a breast MRI are more likely to receive a mastectomy after their diagnosis and may face delays in starting treatment.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.


Premium Drupal Themes by Adaptivethemes